Sonnet BioTherapeutics Files 8-K
| Field | Detail |
|---|---|
| Company | Sonnet Biotherapeutics Holdings, Inc. |
| Form Type | 8-K |
| Filed Date | Apr 4, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-k, regulatory-filing
TL;DR
Sonnet BioTherapeutics filed an 8-K on 4/4/25 for 'Other Events' - details TBD.
AI Summary
Sonnet BioTherapeutics Holdings, Inc. filed an 8-K on April 4, 2025, reporting an "Other Events" item. The filing does not contain specific details about the event itself, but it confirms the company's reporting status and basic corporate information.
Why It Matters
This filing indicates a material event has occurred for Sonnet BioTherapeutics, requiring public disclosure. Investors should look for subsequent filings or press releases for details.
Risk Assessment
Risk Level: low — The filing itself is a standard procedural document and does not contain negative financial or operational information.
Key Players & Entities
- Sonnet BioTherapeutics Holdings, Inc. (company) — Registrant
- April 4, 2025 (date) — Filing Date
- Delaware (jurisdiction) — State of Incorporation
- 001-35570 (identifier) — Commission File Number
- 20-2932652 (identifier) — IRS Employer Identification No.
- 100 Overlook Center, Suite 102 (address) — Principal Executive Offices
- Princeton, New Jersey (location) — Principal Executive Offices Location
- 08540 (zip_code) — Principal Executive Offices Zip Code
- (609) 375-2227 (phone_number) — Registrant's telephone number
FAQ
What specific event is reported under 'Other Events' in this 8-K filing?
The provided text of the 8-K filing does not specify the details of the 'Other Events' being reported.
When was this 8-K filed by Sonnet BioTherapeutics Holdings, Inc.?
The 8-K was filed on April 4, 2025.
What is the Commission File Number for Sonnet BioTherapeutics Holdings, Inc.?
The Commission File Number is 001-35570.
In which state was Sonnet BioTherapeutics Holdings, Inc. incorporated?
Sonnet BioTherapeutics Holdings, Inc. was incorporated in Delaware.
What is the principal executive office address for Sonnet BioTherapeutics Holdings, Inc.?
The principal executive office address is 100 Overlook Center, Suite 102, Princeton, New Jersey 08540.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 4, 2025 regarding Sonnet BioTherapeutics Holdings, Inc..